Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 3/2014

01-03-2014 | Original paper

Body weight in early adulthood, adult weight gain, and risk of endometrial cancer in women not using postmenopausal hormones

Authors: Victoria L. Stevens, Eric J. Jacobs, Alpa V. Patel, Juzhong Sun, Susan M. Gapstur, Marjorie L. McCullough

Published in: Cancer Causes & Control | Issue 3/2014

Login to get access

Abstract

Purpose

High body mass index (BMI) measured in middle age or later is an established risk factor for endometrial cancer. However, whether BMI measured in early adulthood and adult weight change are associated with endometrial cancer risk is less clear, particularly among nonusers of postmenopausal hormones (PMH).

Methods

These associations were investigated among women in the Cancer Prevention Study II Nutrition Cohort. Women taking PMH (n = 11,624, 12 % of all women) were excluded, and the analysis was limited to 33,057 postmenopausal women who did not take PMH. Between enrollment in 1992/1993 and 30 June 2009, 447 women were diagnosed with endometrial cancer. Cox proportional hazards regression was used to calculate hazard rate ratios (RR) and corresponding 95 % confidence intervals (CI) for the association of BMI at age 18, calculated from recalled weight, and weight change between age 18 and 1992, with endometrial cancer incidence.

Results

BMI at age 18 was associated with higher risk of endometrial cancer in multivariable models adjusted for other risk factors (RR 1.29, 95 % CI 1.12–1.49 per 5 BMI units). Similarly, adult weight change was associated with higher risk of endometrial cancer (RR 1.81, 95 % CI 1.66–1.98 per 5 BMI unit change) in multivariable models adjusted for other risk factors.

Conclusions

High BMI at age 18 and greater adult weight gain were strongly associated with risk of endometrial cancer. These results underscore the importance of both avoiding overweight/obesity in young adulthood and preventing weight gain thereafter to minimize risk of this cancer.
Appendix
Available only for authorised users
Literature
1.
2.
Renehan AG, Tyson M, Egger M et al (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578CrossRefPubMed
3.
Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579–591CrossRefPubMed
4.
Kaaks R, Lukanova A, Kurzer MS (2002) Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 11:1531–1543PubMed
5.
Pan L, Blanck HM, Sherry B et al (2012) Trends in the prevalence of extreme obesity among US preschool-aged children living in low-income families, 1998–2010. J Am Med Assoc 308:2563–2565CrossRef
6.
Flegal KM, Carroll MD, Kit BK et al (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. J Am Med Assoc 307:491–497CrossRef
7.
Crosbie EJ, Zwahlen M, Kitchener HC et al (2010) Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 19:3119–3130CrossRefPubMed
8.
Blitzer PH, Blitzer EC, Rimm AA (1976) Association between teen-age obesity and cancer in 56,711 women: all cancers and endometrial cancer. Prev Med 5:20–31CrossRefPubMed
9.
Le Marchand L, Wilkens LR, Mi M-P (1991) Early-age body size, adult weight gain and endometrial cancer risk. Int J Cancer 48:807–811CrossRefPubMed
10.
Shu XO, Brinton LA, Zheng W et al (1992) Relation of obesity and body fat distribution to endometrial cancer in Shanghai, China. Cancer Res 52:3865–3870PubMed
11.
Levi F, La Vecchia C, Negri E et al (1992) Body mass at different ages and subsequent endometrial cancer risk. Int J Cancer 50:567–571CrossRefPubMed
12.
Swanson CA, Potischman N, Wilbanks GD et al (1993) Relation of endometrial cancer risk to past and contemporary body size and body fat distribution. Cancer Epidemiol Biomarkers Prev 2:321–327PubMed
13.
Olson SH, Trevisan M, Marshall JR et al (1995) Body mass index, weight gain, and risk of endometrial cancer. Nutr Cancer 23:141–149CrossRefPubMed
14.
Terry P, Baron JA, Weiderpass E et al (1999) Lifestyle and endometrial cancer risk: a cohort study from the Swedish Twin Registry. Int J Cancer 82:38–42CrossRefPubMed
15.
Weiderpass E, Persson I, Adami HO et al (2000) Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 11:185–192CrossRefPubMed
16.
Jonsson F, Wolk A, Pedersen NL et al (2003) Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry. Int J Cancer 106:594–599CrossRefPubMed
17.
Schouten LJ, Goldbohm RA, van den Brandt PA (2004) Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study. J Natl Cancer Inst 96:1635–1638CrossRefPubMed
18.
Trentham-Dietz A, Nichols HB, Hampton JM et al (2006) Weight change and risk of endometrial cancer. Int J Epidemiol 35:151–156CrossRefPubMed
19.
Xu WH, Xiang YB, Zheng W et al (2006) Weight history and risk of endometrial cancer among Chinese women. Int J Epidemiol 35:159–166CrossRefPubMed
20.
Friedenreich C, Cust A, Lahmann PH et al (2007) Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Cancer Causes Control 18:399–413CrossRefPubMed
21.
Chang SC, Lacey JV Jr, Brinton LA et al (2007) Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev 16:723–730CrossRefPubMed
22.
Thomas CC, Wingo PA, Dolan MS et al (2009) Endometrial cancer risk among younger, overweight women. Obstet Gynecol 114:22–27PubMed
23.
24.
Hosono S, Matsuo K, Hirose K et al (2011) Weight gain during adulthood and body weight at age 20 are associated with the risk of endometrial cancer in Japanese women. J Epidemiol 21:466–473CrossRefPubMed
25.
Lu L, Risch H, Irwin ML et al (2011) Long-term overweight and weight gain in early adulthood in association with risk of endometrial cancer. Int J Cancer 129:1237–1243CrossRefPubMedCentralPubMed
26.
Yang TY, Cairns BJ, Allen N et al (2012) Postmenopausal endometrial cancer risk and body size in early life and middle age: prospective cohort study. Br J Cancer 107:169–175CrossRefPubMedCentralPubMed
27.
Nagle CM, Marquart L, Bain CJ et al (2013) Impact of weight change and weight cycling on risk of different subtypes of endometrial cancer. Eur J Cancer 49:2717–2726CrossRefPubMed
28.
McCullough ML, Patel AV, Patel R et al (2008) Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. Cancer Epidemiol Biomarkers Prev 17:73–79CrossRefPubMed
29.
Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. J Am Med Assoc 288:321–333CrossRef
30.
Sprague BL, Trentham-Dietz A, Cronin KA (2012) A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999–2010. Obstet Gynecol 120:595–603CrossRefPubMedCentralPubMed
31.
Calle EE, Rodriguez C, Jacobs EJ et al (2002) The American Cancer Society Cancer Prevention Study II Nutrition Cohort. Cancer 94:2490–2501CrossRefPubMed
32.
Bergmann MM, Calle EE, Mervis CA et al (1998) Validity of self-reported cancer in a prospective cohort study in comparison with data form state cancer registries. Am J Epidemiol 147:556–562CrossRefPubMed
33.
34.
Cox D (1972) Regression models and life tables. J R Stat Soc B 34:187–202
35.
Sherman ME (2000) Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Path 13:295–308CrossRef
36.
Emons G, Fleckenstein G, Hinney B et al (2000) Hormonal interactions in endometrial cancer. Endocr Relat Cancer 7:227–242CrossRefPubMed
37.
Setiawan VW, Yang HP, Pike MC et al (2013) Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 31:2607–2618CrossRefPubMed
38.
Cole SR, Platt RW, Schisterman EF et al (2010) Illustrating bias due to conditioning on a collider. Int J Epidemiol 39:417–420CrossRefPubMed
39.
Kushi LH, Doyle C, McCullough M et al (2012) American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 62:30–67CrossRefPubMed
Metadata
Title
Body weight in early adulthood, adult weight gain, and risk of endometrial cancer in women not using postmenopausal hormones
Authors
Victoria L. Stevens
Eric J. Jacobs
Alpa V. Patel
Juzhong Sun
Susan M. Gapstur
Marjorie L. McCullough
Publication date
01-03-2014
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 3/2014
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-013-0333-7

Other articles of this Issue 3/2014

Cancer Causes & Control 3/2014 Go to the issue

Original Paper

The influence of genetic ancestry and ethnicity on breast cancer survival associated with genetic variation in the TGF-β-signaling pathway: The Breast Cancer Health Disparities Study

Original paper

Type 2 diabetes and the risk of mortality among patients with prostate cancer

Original Paper

The joint contribution of tumor phenotype and education to breast cancer survival disparity between Hispanic and non-Hispanic white women

Letter to the Editor

Is the trend in primary penile cancer in England real?

Original paper

Fasting insulin and endogenous hormones in relation to premenopausal breast density (Canada)

Original paper

Site-specific proportion cured models applied to cancer registry data
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits